Psychiatric manifestations in systemic lupus erythematosus

Area of Science:

• Rheumatology
• Neurology
• Psychiatry

Background:

• Psychiatric abnormalities affect 17-75% of patients with systemic lupus erythematosus (SLE).
• Diagnosis of active neuropsychiatric lupus (NPSLE) lacks a consensus, leading to varied prevalence rates.
• ACR criteria include cognitive dysfunction, delirium, anxiety, mood disorders, and psychosis in NPSLE.

Purpose of the Study:

• To review clinical manifestations of psychiatric lupus.
• To discuss the pathogenesis of neuropsychiatric lupus (NPSLE).
• To outline current therapeutic options for psychiatric lupus.

Main Methods:

• Literature review of clinical manifestations, pathogenesis, and treatment of psychiatric lupus.
• Analysis of diagnostic criteria and prevalence data for NPSLE.
• Synthesis of information from case studies on treatment strategies.

Main Results:

• Psychiatric manifestations in SLE are diverse, including cognitive, affective, and psychotic disorders.
• Potential pathogenic mechanisms involve vascular injury and autoantibodies.
• Treatment strategies are primarily based on limited case study evidence.

Conclusions:

• Accurate identification and diagnosis of psychiatric phenomena in SLE patients are critical.
• Further research is needed to establish standardized diagnostic criteria and evidence-based treatments for NPSLE.
• Understanding the mechanisms of NPSLE is key to developing effective therapies.